Vertex Pharmaceuticals, Inc.

VRTX

$198.32

-28.1% (1 year change)

Market Cap

$51.9 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$185.33 - $283.45

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

18.78x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $51.9 Billion
Enterprise Value $45.5 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return -28.1%
52-Week High $283.45
52-Week Low $185.33
Beta 0.76
Outstanding Shares 259 Million
Avg 30 Day Volume 2.07 Million

Valuation

P/E Ratio 18.78
PEG 224.67
Earnings per Share $10.50
Price to Sales Ratio 8.26
Price to Book Ratio 5.83
Revenue to Enterprise Value 7.09
EBIT to Enterprise Value 15.0
Total Debt to Enterprise Value 0.01
Debt to Equity 0.06

Profitability

Revenue $6.41 Billion
Gross Profit $5.65 Billion
EBIT $3.03 Billion
Net Income $2.76 Billion
Profit Margin 43.06%
Quarterly Earnings Growth (YoY) +8.4%
Return on Equity 30.76%
Return on Assets 22.8%
Return on Invested Capital 29.81%

News

Earnings Report: Heres what to expect from NASDAQ:GOOGL, NYSE:XPO, NASDAQ:VRTX, NASDAQ:NXGN

Earnings Report: Heres what to expect from NASDAQ:GOOGL, NYSE:XPO, NASDAQ:VRTX, NASDAQ:NXGN

Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis The post Earnings Report: Heres what to expect from NASDAQ:GOOGL, NY...

Stock Market Daily Stock Market Daily, 3 days ago
Leerink Partners Stick to Their Sell Rating for Vertex Pharmaceuticals By Investing.com

Leerink Partners Stick to Their Sell Rating for Vertex Pharmaceuticals By Investing.com

Leerink Partners Stick to Their Sell Rating for Vertex Pharmaceuticals

Investing.com Investing.com, 4 days ago
Vertex Pharmaceuticals Q2 2021 Earnings Preview

Vertex Pharmaceuticals Q2 2021 Earnings Preview

No summary available.

Seeking Alpha Seeking Alpha, 6 days ago